As of February 23, 2021, TransEnterix has been renamed Asensus Surgical, Inc.

Along with the name change, the ticker symbol will change to “ASXC” upon the open of trading on Friday, March 5, 2021. Up until that point, the stock will continue to trade under the company name TransEnterix and ticker symbol TRXC.

If you are an existing investor, your ownership will not be impacted. Beginning on March 5, 2021, your holdings will automatically be renamed as Asensus Surgical, ticker symbol ASXC. Up until that point, the stock will continue to show up as TransEnterix and ticker symbol TRXC.


                                On CTS Letterhead

                                                                   July 19, 1996

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

           Re:        Registration Statement No. 333-07445


           Pursuant to Rule 477(a) promulgated under the Securities Act of 1933,
as amended,  Cellular Technology  Services Company,  Inc. (the "Company") hereby
applies for the withdrawal of the above-captioned Registration Statement and all
exhibits thereto as the Company has determined to no longer proceed to offer the
Common Stock  contemplated to be offered by such  Registration  Statement due to
the effect on the  Company's  share price of the recent  volatility in the stock
market and the fact that the Company has begun to generate cash from  deployment
of its Blackbird(R) Platform and Pretect(TM) Anti-Fraud System which the Company
anticipates  will be  sufficient  to achieve its growth goals that have been set
for 1996. No sales have been made under such Registration Statement.

Very truly yours,


/s/ Michael E. McConnell

Michael E. McConnell
Vice President and
Chief Financial Officer